MADISON, Wisconsin: Eli Lilly is doubling down on manufacturing investments, announcing a US$3 billion expansion of its Wisconsin facility to meet growing demand for its blockbuster diabetes and obesity drugs, Mounjaro and Zepbound.
The move marks another step in the company's effort to scale production as it eyes future growth.
The Kenosha County site, acquired earlier this year, will be significantly e
